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Introduction
DNA delivery approaches currently being applied can be divided into viral and nonviral. Virus-mediated gene delivery is widely used because the ability of viruses such as adenoviruses and retroviruses to enter and express their genomes in the host cell enables high DNA uptake and expression. 1, 2 There are disadvantages with viral systems, however; adenovirus, for example, can be produced in relatively large quantities and efficiently infect cells, albeit transiently, but causes problems because of its immunogenicity. Retroviruses and adenovirus-related viruses can be used to transfect dividing cells stably, but are difficult to produce in high enough titers. [3] [4] [5] Nonviral gene transfer strategies, including receptorand cationic liposome-mediated approaches, afford more flexibility in design and construction. The latter, pioneered by Felgner and co-workers, 6 uses cationic liposomes which form complexes with DNA through charge interactions, and bind to the cell surface to trigger DNA uptake through the cell membrane and protected delivery into the cytoplasm. 7 A number of different cationic liposomes have been developed including lipofectin, 8, 9 lipofectamine, 10 DOTAP 11 and TransfectAce. 12 In receptor-mediated gene delivery, DNA is usually complexed through charge interaction to poly-l-lysine that has been cross-linked to ligands such as transferrin, 13 asialoglycoprotein, 14 mannose 15 or insulin, 16 which confer both cell specificity and receptor-mediated internalization. Multidomain recombinant chimeric proteins as well as peptide-protein conjugates [17] [18] [19] have also been used as an alternative in which one domain or peptide in the chimeric protein enables it to target specific cells, while another acts as a carrier for DNA uptake via receptor-mediated endocytosis. In the case of the Erb-2-endotoxin-GAL4 fusion protein, 20 Erb-2 has been employed as the ligand to target specific cells, endotoxin to facilitate endosome escape after endocytosis, and the yeast transcriptional activator GAL4 as a DNA-binding carrier. A GAL4-invasin fusion 21 has also been used where invasin, through binding to the ␣ 5 ␤ 1 cell surface integrin, can effect internalization of DNA bound to the GAL4 moiety of the fusion protein. GAL4 has also been used in several studies as a constituent of fusion proteins able to bind DNA with high affinity and specificity. 22, 23 While GAL4's transactivation activity appears to be confined to the carboxyl domain of the 881 amino acid protein, its amino terminus has been shown to bind DNA. 24, 25 In particular, the first 147 N-terminal amino acids have been shown to have high affinity for a specific 17 bp oligonucleotide sequence (17mer). 26, 27 Importantly with respect to gene delivery approaches, the first 74 amino acids of GAL4 are able to target ␤-galactosidase to the nucleus, [28] [29] [30] and thus constitute a nuclear localization signal (NLS) which is sufficient and necessary for GAL4 nuclear localization. The ability of GAL4's amino terminal domain to bind to a specific DNA sequence as well as confer nuclear localization on large (Ͼ476 kDa) proteins make it a good candidate for use as part of a gene transfer vehicle. 20, 21 Although the nuclear targeting and DNA-binding activities of GAL4 colocalize to amino acids 1-147, 30 the exact relationship between the two activities has not been defined. This has relevance to nonviral DNA transfer, since GAL4 may enhance DNA transfection through either or both activities, 20 or some other mechanism.
In this study we address the question of GAL4's NLS and DNA-binding activities directly, using the Histagged NLS-containing DNA-binding domain of GAL4 -the protein HisGAL4(1-147) -and two types of reporter plasmids with and without copies of the GAL4 17 bp oligonucleotide recognition sequence, as transfecting constructs. Using gel mobility shift assays and ELISA-based binding assays, we examine binding of HisGAL4 to these plasmids and recognition of HisGAL4(1-147), with and without specifically bound DNA, by the NLSreceptor subunits Kap60/Kap95 31 from yeast and importin 58/97 from mouse (m58/97). 32 Stable and transient transfection assays with HTC rat hepatoma cells were also carried out to demonstrate HisGAL4(1-147)-mediated enhancement of transfection. The results clearly imply mutual exclusivity of the DNA-binding and nuclear targeting activities of GAL4. Interestingly, recognition of the GAL4 NLS was observed only by the ␤-subunits of the respective yeast and importin NLS-receptor subunits (Kap95 and importin 97, respectively), and not by the ␣-subunits (Kap60 and importin 58) which recognise conventional NLSs such as those of SV40 large tumor antigen (T-ag) and the bipartite NLS of the tumor suppressor Rb. 33, 34 When included in transfection experiments, Kap95 was found to reduce GAL4 enhancement of transfection by 80%. The use of GAL4 in gene transfer conjugates should be reconsidered in the light of our findings, the observed facilitation of DNA transfection presumably not the result of enhanced nuclear targeting.
Results
We have been interested for some time in the strategy of incorporating specific DNA-binding proteins into nonviral DNA transfer vehicles as carriers to which cell-specific ligands or modular sequences such as NLSs can be included either within the primary sequence (ie of a fusion protein), or as chemically cross-linked peptides. 35, 36 Specific recognition sequences for the DNAbinding protein can be included within the plasmid to be expressed in the target cell, to enable it to be recognized by the protein and thus be cotransported into the target cells. GAL4 is particularly interesting in this respect since its DNA binding domain, which recognizes a specific 17 bp sequence, 26 appears to include or overlap with an efficient NLS. [28] [29] [30] Although GAL4 has been employed successfully by several groups to enhance receptormediated gene delivery, 20, 21 whether the basis for the apparent enhancement of transfection efficiency is due to improved nuclear targeting, to protection of plasmid DNA from degradation, or to some other mechanism, is unclear.
A GAL4/17mer-carrying reporter system We derived plasmids either containing or not containing the GAL4 17bp recognition sequence (see Materials and methods), and tested their ability to be recognized specifically by bacterially expressed HisGAL4(1-147) protein by carrying out gel shift assays using labelled 17m oligomer in their absence and presence ( Figure 1) . We compared activity to that in the presence of either unlabelled 17m or a non-specific oligomer (22mer). HisGAL4(1-147) was able to bind to labelled 17m, the specificity of binding being demonstrated by the fact that as little as a 10-fold excess unlabelled 17m, but not a 300-fold excess of 22mer, competed for binding (data not shown). 17m-containing plasmids were clearly recognized by HisGAL4(1-147), since they were able to compete labelled 17 binding at as little as a five-fold excess; the specificity of binding was demonstrated by the fact that a 15-fold excess or more of a non-17m containing plasmid was required to compete HisGAL4(1-147) binding ( Figure 1 ). indicated.
P-labelled 17m by increasing concentrations (fold-excess is indicated) of unlabelled plasmids containing the GAL4-specific (17m) or nonspecific (SOS -see Materials and methods) oligomers is shown with the electrophoretic position of both free probe and HisGAL4
used expressed either the neomycin resistance gene (derivatives of plasmid pSV2neo), where quantitative readout was through counting of colonies or measurement of the cellular protein of resistant cells (Figure 2a ), or the Escherichia coli ␤-galactosidase enzyme (derivatives of plasmid pCH110), where ␤-galactosidase activity was monitored after 48 h (Figure 2b ). Increasing concentrations of HisGAL4(1-147) were tested for their effects, transfection efficiency being enhanced maximally (approximately two-fold) at a ratio of about 10 mol HisGAL4(1-147)/mol plasmid (two binding sites per plasmid -see Materials and methods). The effect was specific since transfection using plasmids lacking the 17mer recognition sequence was enhanced to only a slight extent in either permanent or transient expression systems (Figure 2 ). The results represent the first demonstration that GAL4 can enhance both transient and permanent transfection by the calcium phosphate technique. Recognition of the GAL4-NLS by importin and karyopherin ␤-subunits is competed by DNA binding One possibility to explain the facilitation of DNA transfection by HisGAL4(1-147) was enhancement of nuclear targeting through its NLS. Accordingly, before assessing HisGAL4(1-147)-NLS accessibility in complexes with DNA, we measured the affinity of recognition of the GAL4-NLS by the NLS-binding importin and karyopherin subunits using an established and specific ELISAbased binding assay. 33, 34, 38 Experiments were performed with all combinations of importin and karyopherin subunits as GST-fusion proteins -ie ␣-and ␤-subunits alone, or in combination (Figure 3) . Surprisingly, we found that the ␣-subunit in the case of both the mouse and yeast NLS-binding subunits recognized HisGAL4(1-147) quite poorly, in contrast to the ␤-subunit, where maximal binding by the ␣-subunit was less than 15% that of the ␤-subunit in both cases (Figure 3 ; see Table 1 ). The apparent dissociation constants (K d ) for m97-GST and Kap95-GST were about 15 and 21 nm, respectively ( Figure 3 ; see Figure 3 Binding of NLS-binding subunits to HisGAL4 a Measurements were made using an ELISA-based binding assay as described in Materials and methods. 33, 34 Results are for the mean ± s.e.m. for n separate determinations (see Figures 3 and 5 , and data not shown) for maximal binding (expressed as a percentage of the binding of the corresponding ␤-subunit -either Kap95-GST or m97-GST -binding) and the apparent K d as indicated. Proteins expressed in E. coli as described in Materials and methods. 33,34 c Determinations performed in the presence of 17m oligomer at a ratio of 1:200. ND, not able to be determined. Table 1 ). In the case of the combination of Kap60/Kap95-GST and m58/m97-GST, levels intermediate to those bound by the individual subunits were observed (50-60% those of the respective ␤-subunits) with K d s of 38 and 29, respectively ( Figure 3 ; see Table 1 ). It was concluded that, in contrast to more conventional NLSs such as those of T-ag and bipartite NLSs which are recognized directly by the importin/karyopherin ␣-and not ␤-subunits (see Refs 33 and 34; unpublished data), the GAL4-NLS is recognized exclusively by the ␤-subunit of importin/karyopherin. The fact that the presence of the respective ␣-subunit appears to reduce binding on the part of the ␤-subunit implies that the ␣-subunit may in fact compete with the GAL4-NLS for ␤-subunit binding (see Discussion).
Binding of the importin/karyopherin ␤-subunits to HisGAL4(1-147) was also assessed in the presence of bound oligomers using both gel shift ( Figure 4) and ELISA-based ( Figure 5 ; see also Table 1 ) binding assays. In the former, increasing concentrations of Kap95-GST (Figure 4a and b) or m97-GST ( Figure 4c ) were found to compete the binding of labelled 17m to HisGAL4(1-147), seen as a reduction of bound oligomer (to about 25% of that bound in the absence of Kap95 - Figure 4b ) at the HisGAL4(1-147) position. In contrast, control proteins -GST itself and ␤-galactosidase from E. coli -had no effect on HisGAL4(1-147) binding to 17m (not shown), implying the specificity of the effects. No supershift of HisGAL4(1-147) bound by Kap95 was observed ( Figure  4 and data not shown) due to the fact that Kap95 competed 17m binding on the part of HisGAL4 (1-147) . In contrast, a supershifted band was observed where an antibody specific to the amino terminal His-tag of HisGAL4(1-147) was used (Figure 4c, lane 4) . The clear implication from these gel shift experiments was that Kap95 binding to HisGAL4(1-147) competed directly with its specific DNA binding capabilities.
Similar results were obtained with the ELISA assay using either 17m-oligomer ( Figure 5 ; see Table 1 ) or 17m-containing plasmid ( Figure 6 ). A number of experiments were performed where either HisGAL4(1-147) bound to DNA was coated on the microtiter plates before hybridization with Kap95-GST or m97-GST, or coated HisGAL4(1-147) was incubated with Kap95-GST or m97-GST in the presence of oligomer or plasmid, results concurring in that Kap95-GST or m97-GST binding was reduced by specific DNA binding. Figures 5 and 6 illustrate the salient results, demonstrating that the maximal level of Kap95-GST or m97-GST (not shown) binding is reduced maximally by about 85% by specific DNA binding (Table 1 and data not shown), compared with in the presence of a nonspecific DNA, with the K d not significantly affected. This implies that specific DNA-binding excludes binding of Kap95-GST/m97-GST, thus reducing the number of available binding sites. Consistent with this, increasing the ratio of HisGAL4(1-147) to DNA reduced the maximal binding to a lesser extent (see Figure 5 ).
Plasmid DNA could also block Kap95-GST or m97-GST (not shown) binding (Figure 6 ), although at the ratio of HisGAL4(1-147) to plasmid used (that giving maximal enhancement of DNA transfection in both permanent and transient assays -see Figure 2 ), plasmid lacking the GAL4-specific binding site also competed for binding, albeit to a lower extent than that for the plasmid containing the 17m sequence. Clearly, HisGAL4(1-147) is able to bind with reduced affinity to plasmid DNA lacking its specific binding site, which may represent the basis of the observation that HisGAL4(1-147) can enhance transfection by plasmids lacking the 17m sequence to a small extent (see Figure 2 ).
Enhancement of transfection by GAL4 is inhibited by karyopherin ␤
To test whether the mutual exclusivity of GAL4 nuclear targeting and DNA binding could directly influence GAL4-mediated enhancement of transfection, we carried out experiments in which cells were transfected using the calcium phosphate technique with 17m-containing plasmid-DNA in the presence of HisGAL4(1-147) and in the absence or presence of a molar equivalent of either Kap95-GST or GST ( Figure 7) . As predicted based on the results within the previous section, inclusion of Kap95-GST, in contrast to that of GST alone, was found to inhibit transfection by about 80%, implying that this was through binding of Kap95 to the GAL4-NLS displacing the bound plasmid. The limited enhancement of transfection by GAL4 indicated above (see Figure 2) would thus appear to be directly attributable to the fact that GAL4's nuclear targeting and DNA-binding activities compete with one another.
Figure 4 HisGAL4(1-147)-DNA recognition is inhibited by NLS-binding proteins as shown by electrophoretic mobility shift assays. Incubations were performed as described in Materials and methods using 1 pmol of HisGAL4(1-147) per lane. (a) Decreasing amounts of Kap95-GST (lanes 1-5 denote 1200, 720, 480, 240 and 0 pmol, respectively) were added to the incubation. (b) Quantitative data from the gel shown in (a) using phosphorimaging; results are shown as a percentage of total bound 17m. (c) RGS His-antibody can induce a supershift of 17m-bound HisGAL4(1-147). Lanes 2 and 3 (600 and 1200 pmol, respectively) indicate that m97-GST, like Kap95-GST, can compete with labelled 17m for binding to HisGAL4(1-147).

Figure 5 Binding of NLS-binding subunits to HisGAL4(1-147) in the presence of various amounts of oligomer as quantified using an ELISAbased assay. Experiments were performed as described in the legend to
Discussion
This study encompasses the first direct analysis of NLS recognition/accessibility in vehicles for nonviral DNA transfer. In particular, it shows for the first time that DNA binding and NLS activity on the part of GAL4 appear to be mutually exclusive. This was demonstrated using both gel-shift assays, where the NLS-receptor ␤-subunits competed specific 17m oligomer binding by HisGAL4 , and in an ELISA-based binding assay where either specific oligomer or plasmid containing it could block NLS-receptor ␤-subunit binding to HisGAL4 . DNA binding presumably either masks the GAL4-NLS, or induces conformational change that prevents its recognition by the cellular NLS-receptor; in similar fashion, NLS-receptor ␤-subunit binding must mask the GAL4 DNA-binding domain or prevent correct folding.
The observation that DNA binding and the NLS of GAL4 are mutually exclusive has profound implications for nonviral gene delivery; since DNA-bound GAL4 appears to lack a recognizable NLS, and the GAL4-NLSbinding importin/karyopherin ␤-subunit in fact appears to be able to induce release of bound DNA from GAL4 (Figures 4-6 , and data not shown). That this can directly impair GAL4 enhancement of transfection is shown by the fact that exogenously added Kap95 severely reduces transfection efficiency (see Figure 7) . Clearly, GAL4-mediated enhancement of DNA transfection is not through NLS-mediated nuclear targeting (see Refs 20 and 21), but must be attributable to other effects of GAL4, such as DNA compaction to enable more efficient cell entry, or protection of the DNA from degradation after entry into the cell. Whether addition of a second more conventional NLS, such as that of T-ag, into GAL4 may improve nuclear targeting and enhancement of transfection is currently being tested.
This study shows for the first time that the GAL4-NLS exhibits high affinity for the NLS-receptor ␤-subunit, rather than for the NLS-receptor ␣-subunit or the ␣/␤-subunit combination, in contrast to conventional NLSs such as those of T-ag and bipartite NLSs and is thus a novel type of NLS. We have demonstrated efficient and rapid nuclear import of HisGAL4(1-147) in in vitro nuclear import assays (unpublished). That the NLSreceptor ␤-subunit, rather than the ␣ or ␣/␤-subunits, can bind specific NLSs has recently been shown for the NLS of the T cell protein tyrosine phosphatase (TCPTP). 39 Interestingly, in this context the GAL4 amino terminus (RLKKLKCSKEKPKCAKCLKNNWECRYSP KTKR 46 ) exhibits certain similarity to the TCPTP NLS (RKRIREDRKATTAQKVQQMKQRLNENERKRKR 381 ), both of which resemble the amino terminal region of ␣-importin/karyopherin (m58:RFKNKGKDSTEMRRRRI EVNVELRKAKK 43 ). Whether GAL4 recognition by ␤-importin/karyopherin may be through its simulating ␣-subunit binding to the ␤-subunit is currently under investigation, although, consistent with this idea, the ␣-subunit appears to be able to compete ␤-subunit binding to GAL4 in the ELISA assay (Figure 3) . The GAL4-NLS is clearly novel and distinct from that of TCPTP in that its recognition by NLS-binding proteins is regulated by DNA binding. Since importin ␣ does not recognize it, the conventional NLS-mediated nuclear import pathway where importin ␤ remains bound to the nuclear pore and importin ␣ enters the nucleus bound to the NLS-containing protein is clearly not operative in the case of GAL4. Accordingly, an intriguing possibility is, that following transport through the nuclear pore, DNA binding could play an important role in triggering release of GAL4 from the ␤-subunit and into the nucleoplasm. Understanding of the molecular details of this novel NLS-mediated nuclear import pathway will be important in optimising nonviral DNA delivery approaches where GAL4 is used as one component of a larger conjugate.
It is unclear at this stage whether other DNA-binding proteins where the NLS overlaps or is close to the DNAbinding domain will turn out to be similar in terms of the novel properties of the GAL4-NLS, and particularly in terms of the mutual exclusivity of NLS and DNA binding activities. Future work in this laboratory will address this question directly, using the approaches described here, with the ultimate aim being to develop a fusion protein able to fulfil the dual role of DNA carrier and nuclear targeting vehicle with high efficiency.
Materials and methods
Cell lines HTC rat hepatoma (a derivative of Morris hepatoma 7288C) cells were cultured in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum as described previously. 40, 41 Mammalian expression vectors A 44 bp oligonucleotide (5Ј-GATCGGAAGACTCTCCTC CGAGCGCTCGGAAGACTCTCCTCCGC-3Ј), containing tandem repeats of the 17mer shown to be specifically recognised by the GAL4 DNA binding domain, 25, 42 was annealed with the complementary oligonucleotide (5Ј-GATCGCGGAGGAGAGTCTTCCGAGCGCTCGGAGG AGAGTCTTCC-3Ј) to yield a double stranded oligomer (17m) which was then ligated into the unique BamHI sites of the reporter plasmids pSV2neo 43 and pCH110. 44 These confer SV40 promoter directed expression of the neomycin resistance gene that confers resistance to the antibiotic G418, and the E. coli enzyme ␤-galactosidase, respectively. The resultant plasmids were pSV2neo-17m and pCH110-17m, respectively.
Protein expression
The plasmid vector pHisGal, 27 which allows IPTG inducible expression of amino terminally His-tagged GAL4 amino acids 1-147, was obtained from Lienhard Schmitz (University of Freiburg, Freiburg, Germany). HisGAL4(1-147) (19 kDa) was purified using Ni-NTA agarose (Qiagen, Clifton Hill, Victoria, Australia). 27 Protein concentration was determined using the dye binding assay of Bradford, 45 with bovine serum albumen (BSA) as a standard. The NLS-binding mouse importin 58 and 97 (m58 and m97) 32 and yeast karyopherin 60 and 90 (Kap60 and Kap95) 31 were expressed as glutathione-Stransferase (GST) fusion proteins and purified as described previously. 38 GST-free Kap60 and m58 was prepared by thrombin cleavage as described. 33, 34 Electrophoretic mobility shift assays 17m was prepared by annealing (see above) and then purified by preparative polyacrylamide gel electrophoresis, before radiolabelling with ␥-32 P ATP (Bresatec, Thebarton, SA, Australia) using T4 polynucleotide kinase (Biolabs, Beverley, MA, USA). Unincorporated radionucleotide was removed using a sepharose Nick spin column (AMRAD Pharmacia Biotech, Boronia, Victoria, Australia), and incorporated radioactivity quantified by scintillation counting (Packard 1900CA-Packard, Downers Grove, IL, USA). HisGAL4(1-147) binding to labelled 17m was assessed by incubating various amounts of the protein and 0.2 ng of the radiolabelled oligomer in binding buffer (BB1: 10 m ZnCl 2 , 25 mm Hepes-KOH pH 7.9, 4 mm MgCl 2 , 7% v/v glycerol, 2 nm DTT, 1 mg/ml BSA, 80 mm KCl) at room temperature for 20 min, 27 before electrophoresis on a 5% polyacrylamide gel containing 2% glycerol in 0.5 × Tris-borate buffer EDTA (TBE: 25 mm Tris, 25 mm Boric acid, 0.5 mm EDTA, 1 mm MgCl 2 ). The dried gel was either exposed to radiographic Biomax film (Eastman Kodak, Rochester, NY, USA), or a phosphorimager (Molecular Dynamics, Sunnyvale, CA, USA) was used to quantify the levels of bound and free radiolabelled oligomer. 33, 40 For competition experiments, labelled 17m was incubated with HisGAL4(1-147) in the presence of increasing amounts of unlabelled 17m or of a sequence-unrelated oligomer (22mer: 5Ј-GATCTGATTGGGTTTCTCCCAG-TAGCGCTTGATTGGGTTTCTCCCAGT-3Ј), or with plasmids with (pSV2neo-17m and pCH110-17m) or without the 17m sequence. The latter included plasmids containing the 46-mer SOS (5Ј-GATCTGCTGTATATATA TACAGCGCTACTGTATATACACCCAGGGC-3Ј which contains specific binding sites in tandem for the DNAbinding protein lexA) inserted into the BamHI site of plasmids pSV2neo or pCH110 as for the 17m and complimentary oligomers above. Where experiments with NLSbinding proteins were performed, increasing amounts of Kap60, Kap95, m58 or m97 were added to 0.12 pmol of HisGAL4(1-147) and 0.15 pmol of radiolabelled 17m. For supershift experiments, the RGS His antibody (Qiagen) specific for the His tag sequence and reactive with HisGAL4(1-147) as shown in Western blots, was used at a dilution of 1/2000.
DNA transfer
For both transient expression assays, and where permanent transfectants were selected, HTC cells were transfected using the calcium phosphate procedure. 37 Reporter plasmid (0.5 pmol) was incubated with increasing amounts of HisGAL4(1-147) for 15 min in BB1, before the addition of 125 mm CaCl 2 and 2 × BES buffer (50 mm BES pH 6.95, 280 mm NaCl, 1.5 mm Na 2 HPO 4 ); in some experiments, either Kap95-GST or GST itself were included at equimolar ratios with HisGAL4(1-147). The protein-DNA mixture was then added to cells (60% confluent) which had been seeded overnight in six-well costars at a density of 2 × 10 5 cells per well. To select permanent transfectants, plasmids pSV2neo and pSV2neo-17m were used and G418 (0.6 mg/ml) was added 48 h after transfection. Plates were washed and replenished with fresh medium containing antibiotic 7 days after transfection, and washed, fixed and stained with 0.1% methylene blue/50% ethanol for 30 min 14 days after transfection. Plates were then washed in water four times by immersion, air dried overnight, and the number of colonies per plate counted. In some cases, and particularly where colonies were too numerous to count, dye was extracted with 1% N-lauroyl-sarcosine (Sigma, St Louis, MO, USA) in PBS and absorbance at 630 nm measured to provide an estimation of cell protein. 46, 47 For transient expression, HTC cells were transfected with pCH110 or pCH110-17m plasmids and ␤-galactosidase activity in transfected cells was analysed 48 h later using the Galacto-light Plus chemiluminescence assay from TROPIX (Bedford, MA, USA), according to the manufacturer's specifications. Results were corrected for protein concentration in cell extracts, determined as above.
ELISA-based binding assay
The binding of Kap95-GST, Kap60-GST, m97-GST and m58-GST to HisGAL4(1-147) in the absence and presence of various concentrations of the 17m or SOS annealed oligomers, or plasmids with or without the 17mer sequence was assayed using an established and specific ELISAbased binding assay. 33, 34, 38 Briefly, this involved coating 96-well microtitre plates with HisGAL4(1-147), hybridization with increasing concentrations of importin/ karyopherin subunits, and detection of bound importin-GST using goat anti-GST primary (AMRAD Pharmacia Biotech), and alkaline phosphatase-coupled rabbit antigoat secondary antibodies, and the substrate p-nitrophenyl phosphate (p-NPP). 33, 34 Absorbance measurements were performed over 90 min using a plate reader (Molecular Devices, Menlo Park, CA, USA), and values corrected by subtracting absorbance both at 0 min, and in wells incubated without importin. 33, 34 
